Robotic prostate surgery developed through decades of advances in minimally invasive surgery, computer-assisted instruments and enhanced surgical imaging. These developments eventually gave you access to surgeon-controlled systems that are now widely used for radical prostatectomy.
The robotic system does not decide how to perform your operation or move independently. Your surgeon controls the camera and surgical instruments from a console, supported by the wider operating theatre team.
Prostate Surgery Before Robotics
Radical prostatectomy was traditionally performed through an incision in the lower abdomen, allowing the surgeon to access and remove the prostate directly. Open surgery remains an effective treatment and is still performed in selected circumstances.
Compared with open surgery, minimally invasive techniques are generally associated with smaller incisions, lower blood loss and shorter hospital stays. They do not remove the recognised risks of urinary leakage, erectile dysfunction or other complications.
The Arrival of Laparoscopic Prostate Surgery
Laparoscopic prostatectomy allowed your surgeon to remove your prostate using a camera and long instruments inserted through small abdominal incisions. This reduced the size of your surgical wounds and could support a shorter early recovery than open surgery.
However, conventional laparoscopic instruments had a limited range of movement, and your surgeon worked while viewing a two-dimensional screen. These technical challenges encouraged the development of systems offering improved vision and more flexible instrument control.
The PUMA Robotic-Arm Milestone
In 1985, an industrial PUMA robotic arm was used to position a guide during a CT-guided stereotactic brain biopsy. The original published technical report identifies the system as a PUMA 200, although some later historical accounts have described it as a PUMA 560.
The robotic arm helped position and stabilise the guide rather than performing the biopsy independently. This early application demonstrated how computer-controlled equipment could support accurate instrument positioning during a delicate medical procedure.
PROBOT Brought Robotics Into Urology

The PROBOT was developed through collaboration between Imperial College London and clinicians at Guy’s Hospital. It emerged during the late 1980s and was used clinically for prostate surgery in the early 1990s.
Your surgeon defined the area of obstructing prostate tissue to be treated, after which the device could carry out programmed cutting movements under medical supervision. Unlike a modern robot-assisted prostatectomy system, the PROBOT could complete a limited part of the procedure automatically rather than continuously translating your surgeon’s hand movements.
AESOP Introduced Robotic Camera Control
AESOP was a robotic arm designed to hold, position and stabilise a laparoscopic camera. Later versions allowed your surgeon to move the camera using voice commands rather than relying completely on a human camera assistant.
AESOP entered clinical use during the early 1990s. Later versions introduced additional controls, including voice-operated camera positioning. It improved your surgeon’s control of the surgical view but did not perform the operation or move the surgical instruments.
The ZEUS Surgical System
The ZEUS Surgical System was an early robotic platform that allowed surgeons to control instruments remotely using a console. It helped demonstrate how robotic technology could enable precise movements and even long-distance (telesurgery) procedures.
Key Features of the ZEUS System
| Aspect | Explanation | Significance |
| Developer | Created by Computer Motion | One of the first companies to advance surgical robotics |
| System design | Combined robotic arms with the AESOP camera controller | Allowed controlled, stable instrument and camera movement |
| Surgeon control | Operated from a console translating hand movements into instrument actions | Improved precision and reduced tremor |
| Telesurgery | Enabled remote procedures, including the 2001 transatlantic “Lindbergh operation” | Demonstrated the potential for surgery across long distances |
| Historical milestone | Preceded modern robotic systems before merger with Intuitive Surgical in 2003 | Helped shape the development of current robotic surgery platforms |
The Development of the da Vinci System
Intuitive Surgical was founded in 1995 and developed a console-controlled platform combining magnified three-dimensional vision with articulated surgical instruments.
The first commercial da Vinci system received US FDA clearance for general laparoscopic procedures in July 2000. A specific US clearance covering prostatectomy procedures followed in May 2001. Regulatory clearance allowed trained surgeons to use the system for these procedures but did not establish that it was superior to open or conventional laparoscopic surgery for every patient.
The First Robotic Radical Prostatectomy
The first widely reported robot-assisted laparoscopic radical prostatectomy using the da Vinci system was performed by Jochen Binder and Wolfgang Kramer in Frankfurt in May 2000. Other European teams, including surgeons in Paris, reported early procedures during the same period and contributed to the technique’s initial development.
These operations demonstrated that your prostate could be removed using instruments controlled remotely by your surgeon from a console. Early reports involved very small numbers of patients, so they established technical feasibility rather than proving better long-term outcomes.
The Vattikuti Technique

From 2001, Professor Mani Menon and his colleagues at the Vattikuti Urology Institute developed a structured method of robotic radical prostatectomy known as the Vattikuti Institute Prostatectomy.
The team reported its first 100 operations from procedures performed between August 2001 and May 2002. Publishing and standardising the surgical steps helped other surgical teams learn the technique and develop robotic prostatectomy programmes.
Why Prostate Surgery Adopted Robotics Quickly
Your prostate lies deep within your pelvis near your urinary sphincter, rectum and the nerve bundles involved in erections. This confined position means that clear vision, controlled instrument movement and careful dissection are particularly important.
Robotic systems give your surgeon magnified three-dimensional vision, tremor filtration and wristed instruments. These features can make complex movements easier, but they do not guarantee better urinary, sexual or cancer outcomes.
The Surgeon Remained in Control
Modern robotic systems are more accurately described as surgeon-controlled telemanipulators. Your surgeon sits at a console and directly controls the camera and every operative instrument throughout your procedure.
The system may reduce tremor and scale your surgeon’s movements, but it cannot decide where to cut, whether nerves can safely be preserved or how much tissue should be removed. These decisions remain with your surgeon and surgical team.
Improvements in Vision and Instrument Movement
A robotic system gives your surgeon a magnified three-dimensional view of the surgical area. This provides greater depth perception than conventional two-dimensional laparoscopy and may help your surgeon identify fine anatomical structures more clearly.
The wristed instruments also provide a greater range of movement than straight laparoscopic tools. However, your result still depends on factors such as your cancer position, anatomy, baseline health and your surgeon’s experience.
Robotic Surgery Expanded Internationally

During the 2000s, hospitals across the United States, Europe and other regions began adopting robotic systems for prostate surgery. This meant you were increasingly likely to be offered a robotic-assisted procedure as the technology became more widely available.
Radical prostatectomy became one of the operations most closely linked to robotics. Its rapid expansion was influenced by patient demand, hospital investment, technological advantages over conventional laparoscopy and the development of structured surgical techniques and training.
The Growth of Robotic Prostatectomy in the UK
Robot-assisted prostatectomy expanded across NHS and private hospitals during the 2000s and 2010s. Hospital Episode Statistics recorded 6,651 radical prostatectomies in England during 2014.
The BAUS audit received information on 5,814 operations performed in England, representing approximately 87% of the national total. Within these submitted cases, 58.5% were robot-assisted, 26.7% were laparoscopic, 13.4% were open and the approach was not recorded in 1.4%. These figures provide a historical snapshot of participating cases and should not be presented as the current national distribution.
The da Vinci Xi Generation
The da Vinci Xi system received US FDA clearance in 2014 and introduced redesigned robotic arms, a movable camera and greater flexibility in port placement. These developments aimed to improve access during surgery and support a more efficient operating theatre setup.
- System design: Redesigned robotic arms allow improved range of motion and positioning during procedures
- Camera mobility: A movable camera provides better visual access to different areas during surgery
- Port flexibility: Surgeons can position instruments more freely to suit the procedure and patient anatomy
- Workflow efficiency: Changes were designed to support smoother operating theatre processes
- Safety considerations: Outcomes still depend on factors such as your health, cancer characteristics and the experience of the surgical team
While the technology introduced important improvements, it does not automatically make surgery safer on its own. The overall outcome continues to depend on careful planning, surgical expertise and your individual clinical situation.
Surgical Techniques Continued to Evolve
Your surgeon may use techniques intended to preserve your urinary sphincter, reconstruct supporting tissues and protect the nerve bundles involved in erections when cancer control allows.
A Retzius-sparing approach reaches your prostate from behind your bladder and may support earlier urinary control in selected patients. It is not suitable for every cancer, and your surgeon will choose the approach according to your anatomy, cancer position and clinical needs.
Training Became Increasingly Structured

Your surgeon requires specific training in console control, patient positioning, instrument use, surgical technique and the management of emergencies or equipment problems.
Training may include simulation, observation, supervised operating, mentoring and formal assessment. Your outcome also depends on the wider team, including the bedside assistant, anaesthetists, nurses and technical staff.
Evidence and Expectations Became More Balanced
Compared with open radical prostatectomy, robot-assisted surgery is generally associated with less blood loss, fewer transfusions and a shorter hospital stay. These benefits mainly relate to your operation and early recovery.
The robotic platform alone does not guarantee better long-term cancer control, urinary continence or erectile function. Your outcome also depends on your cancer characteristics, baseline function, surgical technique and the experience of your surgeon and treatment centre.
Single-Port Systems and the Latest Generation
Single-port robotic systems allow a flexible camera and several articulated instruments to enter through one main access port, although your surgeon may still require an additional assistant port.
Newer robotic platforms continue to introduce developments in imaging, computing, instrument control and surgeon feedback. Availability varies between healthcare systems, and further evidence is needed to determine whether these technological developments improve long-term cancer control, urinary function, sexual function or recovery.
Myth vs Fact
| Myth | Fact |
| The robot performs your operation independently. | Your surgeon directly controls the instruments and makes every surgical decision. |
| Robotic prostatectomy was invented suddenly in 2000. | It developed from decades of advances in imaging, laparoscopy, robotics and telesurgery. |
| The PROBOT worked like a modern da Vinci system. | The PROBOT performed programmed cutting under supervision, while modern systems continuously translate your surgeon’s movements. |
| There is one universally agreed first robotic prostatectomy. | Early robot-assisted procedures were reported in both Paris and Frankfurt during 2000. |
| More advanced equipment guarantees better cancer control. | Your outcome depends heavily on your cancer, surgical technique and your surgeon’s experience. |
| Robotic surgery removes the risk of leakage or erection difficulties. | Both remain recognised possible effects of radical prostatectomy. |
| Single-port surgery always means you have only one incision. | Your surgeon may still require additional access for assistance or safety. |
| Open prostatectomy is no longer effective. | It remains an established surgical option in selected circumstances. |
Key Takeaways
- Robotic surgery developed from earlier image-guided and laparoscopic technologies.
- The PROBOT introduced supervised autonomous robotics into urology.
- Modern prostatectomy systems are controlled continuously by the surgeon.
- Early robot-assisted radical prostatectomies were performed in Europe in 2000.
- The Vattikuti technique helped standardise robotic prostatectomy during the early 2000s.
- By 2014, robot-assisted surgery was the most commonly recorded approach among the radical prostatectomies submitted to the BAUS audit in England.
- Robotic surgery usually results in less blood loss and a shorter hospital stay than open surgery.
- Long-term continence, erectile function and cancer control depend on several factors beyond the surgical platform.
- Surgeon and team experience remain central to outcomes.
- Single-port and newer robotic platforms represent more recent technological developments.
Frequently Asked Questions
1. What is robotic prostate surgery?
Robotic prostate surgery is a minimally invasive operation in which your surgeon controls specialised instruments from a console. The system provides magnified three-dimensional vision and articulated instruments but does not perform your operation independently.
2. When did robotic prostate surgery begin?
Robotic prostate surgery developed over several decades. The first widely reported da Vinci-assisted radical prostatectomy was performed in Frankfurt in May 2000, with other European teams reporting early procedures during the same period. More structured and reproducible techniques were developed during the following years.
3. Did robots replace traditional prostate surgery?
No. Open and conventional laparoscopic prostatectomy remain valid surgical approaches. Robot-assisted surgery became more common because of its technical features and early-recovery benefits, not because other methods stopped being effective.
4. What was prostate surgery like before robotics?
Before robotic surgery, your prostate was usually removed through open surgery using a larger abdominal incision. Open surgery remains effective but is generally associated with more blood loss and a longer hospital stay than minimally invasive approaches.
5. What role did laparoscopic surgery play in development?
Laparoscopic surgery introduced smaller incisions and camera-guided prostate removal. Its straight instruments and two-dimensional view could make the procedure technically demanding, contributing to the development of robotic platforms.
6. What is the da Vinci Surgical System?
The da Vinci system is a surgeon-controlled robotic platform that provides three-dimensional vision and articulated instruments. Its first commercial system received US FDA clearance for laparoscopic surgery in July 2000.
7. Does the robot perform the surgery on its own?
No. Your surgeon controls every movement from a console and makes all decisions during your operation. The system cannot operate or make clinical decisions independently.
8. Why did robotic prostate surgery become popular?
Robotic prostatectomy became popular because its vision and instruments are well suited to working within your confined pelvis. Patient demand, hospital investment, structured training and the challenges of conventional laparoscopy also contributed to its adoption.
9. Is robotic prostate surgery better than other methods?
You may experience less blood loss and a shorter hospital stay with robotic surgery than with open surgery. Your long-term cancer, urinary and sexual outcomes also depend on your health, cancer characteristics and your surgeon’s experience.
10. How has robotic prostate surgery evolved over time?
Robotic systems have evolved through improvements in imaging, instrument movement, single-port access, computing and surgeon control. These developments do not guarantee a better result for every patient and still require clinical evaluation.
Final Thoughts: The Evolution of Robotic Prostate Surgery
Robotic prostate surgery has developed from early experimental systems into a widely used approach that supports precision, control and minimally invasive treatment. Advances in imaging, instrument design and surgical training have allowed your surgeon to perform complex procedures with enhanced visualisation, dexterity and instrument control, particularly in the confined space of the pelvis.
While robotic systems have improved aspects of recovery and surgical technique, your overall outcome still depends on factors such as your cancer characteristics, general health and your surgeon’s experience. Technology continues to evolve, but careful patient selection and expert surgical care remain central to achieving the best results.
If you are looking for a robotic prostate surgery clinic in London, you can contact us at Prostate Clinic London to discuss your treatment options and arrange your consultation.
References
- Barakat, B., Othman, H., Gauger, U., Wolff, I., Hadaschik, B. and Rehme, C. (2022) ‘Retzius-sparing radical prostatectomy versus robot-assisted radical prostatectomy: which technique is more beneficial for prostate cancer patients (MASTER Study)? A systematic review and meta-analysis’, European Urology Focus, 8(4), pp. 1060–1071. Available at: https://pubmed.ncbi.nlm.nih.gov/34429272/
- British Association of Urological Surgeons (no date) Robotic-assisted laparoscopic removal of the prostate for cancer. Available at: https://www.baus.org.uk/patients/information_leaflets/180/roboticassisted_laparoscopic_removal_of_prostate_for_cancer_rarp
- British Association of Urological Surgeons (no date) Summary and timescale of the data: radical prostatectomy. Available at: https://www.baus.org.uk/patients/surgical_outcomes/radical_prostatectomy/timescales.aspx
- Brassetti, A. et al. (2023) ‘Robotic surgery in urology: history from PROBOT® to HUGO™’, Sensors, 23(16), article 7104. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10458477/
- Cao, L., Yang, Z., Qi, L. and Chen, M. (2019) ‘Robot-assisted and laparoscopic versus open radical prostatectomy in clinically localised prostate cancer: perioperative, functional and oncological outcomes—a systematic review and meta-analysis’, Medicine, 98(22), article e15770. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6709105/
- Coughlin, G.D. et al. (2018) ‘Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study’, The Lancet Oncology, 19(8), pp. 1051–1060. Available at: https://pubmed.ncbi.nlm.nih.gov/30017351/
- Hakenberg, O.W. (2018) ‘A brief overview of the development of robot-assisted radical prostatectomy’, Arab Journal of Urology, 16(3), pp. 293–296. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6104667/
- Imperial College London (no date) PROBOT. Available at: https://www.imperial.ac.uk/a-z-research/mechatronics-in-medicine/research/completed-projects/probot/
- Kwoh, Y.S., Hou, J., Jonckheere, E.A. and Hayati, S. (1988) ‘A robot with improved absolute positioning accuracy for CT-guided stereotactic brain surgery’, IEEE Transactions on Biomedical Engineering, 35(2), pp. 153–160. Available at: https://pubmed.ncbi.nlm.nih.gov/3280462/
- Menon, M., Shrivastava, A., Sarle, R., Hemal, A. and Tewari, A. (2003) ‘Vattikuti Institute Prostatectomy: a single-team experience of 100 cases’, Journal of Endourology, 17(9), pp. 785–790. Available at: https://pubmed.ncbi.nlm.nih.gov/14642044/
- National Institute for Health and Care Excellence (2019) Prostate cancer: diagnosis and management. NICE guideline NG131. Last updated 15 December 2021 and last reviewed 13 August 2025. Available at: https://www.nice.org.uk/guidance/ng131
- Pugin, F., Bucher, P. and Morel, P. (2011) ‘History of robotic surgery: from AESOP® and ZEUS® to da Vinci®’, Journal of Visceral Surgery, 148(5 Suppl), pp. e3–e8. Available at: https://pubmed.ncbi.nlm.nih.gov/21974854/
- Royal College of Surgeons of England (2025) Robotic-assisted surgery: a pathway to the future. Available at: https://www.rcseng.ac.uk/standards-and-research/standards-and-guidance/good-practice-guides/robotic-assisted-surgery/
- Wolfram, M. et al. (2003) ‘Robotic-assisted laparoscopic radical prostatectomy: the Frankfurt technique’, World Journal of Urology, 21(3), pp. 128–132. Available at: https://pubmed.ncbi.nlm.nih.gov/12851781/